title: Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infection.
abstract: The mechanisms by which viruses persist and particularly those by which viruses actively contribute to their own latency have been elusive. Here we report the existence of opposing functions encoded by genes within a polycistronic locus of the human cytomegalovirus (HCMV) genome that regulate cell type-dependent viral fates: replication and latency. The locus, referred to as the UL133-UL138 (UL133/8) locus, encodes four proteins, pUL133, pUL135, pUL136, and pUL138. As part of the ULb' region of the genome, the UL133/8 locus is lost upon serial passage of clinical strains of HCMV in cultured fibroblasts and is therefore considered dispensable for replication in this context. Strikingly, we could not reconstitute infection in permissive fibroblasts from bacterial artificial chromosome clones of the HCMV genome where UL135 alone was disrupted. The loss of UL135 resulted in complex phenotypes and could ultimately be overcome by infection at high multiplicities. The requirement for UL135 but not the entire locus led us to hypothesize that another gene in this locus suppressed virus replication in the absence of UL135. The defect associated with the loss of UL135 was largely rescued by the additional disruption of the UL138 latency determinant, indicating a requirement for UL135 for virus replication when UL138 is expressed. In the CD34(+) hematopoietic progenitor model of latency, viruses lacking only UL135 were defective for viral genome amplification and reactivation. Taken together, these data indicate that UL135 and UL138 comprise a molecular switch whereby UL135 is required to overcome UL138-mediated suppression of virus replication to balance states of latency and reactivation.
  
  
  OBJECTIVE
  Mechanisms by which viruses persist in their host remain one of the most poorly understood phenomena in virology. Herpesviruses, including HCMV, persist in an incurable, latent state that has profound implications for immunocompromised individuals, including transplant patients. Further, the latent coexistence of HCMV may increase the risk of age-related pathologies, including vascular disease. The key to controlling or eradicating HCMV lies in understanding the molecular basis for latency. In this work, we describe the complex interplay between two viral proteins, pUL135 and pUL138, which antagonize one another in infection to promote viral replication or latency, respectively. We previously described the role of pUL138 in suppressing virus replication for latency. Here we demonstrate a role of pUL135 in overcoming pUL138-mediated suppression for viral reactivation. From this work, we propose that pUL135 and pUL138 constitute a molecular switch balancing states of latency and reactivation.
authors.affiliation: BIO5 Institute, University of Arizona, Tucson, Arizona, USA.
authors.forename: Mahadevaiah
authors.initials: M
authors.lastname: Umashankar
authors.forename: Michael
authors.initials: M
authors.lastname: Rak
authors.forename: Farah
authors.initials: F
authors.lastname: Bughio
authors.forename: Patricia
authors.initials: P
authors.lastname: Zagallo
authors.forename: Katie
authors.initials: K
authors.lastname: Caviness
authors.forename: Felicia D
authors.initials: FD
authors.lastname: Goodrum
mesh_terms: D022202:Chromosomes, Artificial, Bacterial; D003001:Cloning, Molecular; D003587:Cytomegalovirus / Q000235:genetics*; D003586:Cytomegalovirus Infections / Q000235:genetics / Q000503:physiopathology*; D017931:DNA Primers / Q000235:genetics; D005347:Fibroblasts; D056426:Genetic Loci / Q000235:genetics; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D015151:Immunoblotting; D046529:Microscopy, Electron, Transmission; D014764:Viral Proteins / Q000235:genetics*; D017735:Virus Latency / Q000235:genetics*; D014779:Virus Replication / Q000235:genetics*
chemical_list: D017931:DNA Primers; D014764:Viral Proteins